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Abstract: Elk-1 is a transcription factor that binds together with a dimer of the serum response factor
(SRF) to the serum-response element (SRE), a genetic element that connects cellular stimulation
with gene transcription. Elk-1 plays an important role in the regulation of cellular proliferation
and apoptosis, thymocyte development, glucose homeostasis and brain function. The biological
function of Elk-1 relies essentially on the interaction with other proteins. Elk-1 binds to SRF and
generates a functional ternary complex that is required to activate SRE-mediated gene transcription.
Elk-1 is kept in an inactive state under basal conditions via binding of a SUMO-histone deacetylase
complex. Phosphorylation by extracellular signal-regulated protein kinase, c-Jun N-terminal protein
kinase or p38 upregulates the transcriptional activity of Elk-1, mediated by binding to the mediator
of RNA polymerase II transcription (Mediator) and the transcriptional coactivator p300. Strong
and extended phosphorylation of Elk-1 attenuates Mediator and p300 recruitment and allows the
binding of the mSin3A-histone deacetylase corepressor complex. The subsequent dephosphorylation
of Elk-1, catalyzed by the protein phosphatase calcineurin, facilitates the re-SUMOylation of Elk-
1, transforming Elk-1 back to a transcriptionally inactive state. Thus, numerous protein–protein
interactions control the activation cycle of Elk-1 and are essential for its biological function.
Keywords: c-Fos; Egr-1; histone deacetylase; MAP kinase; mediator; SRF; SUMO
1. Introduction
The human genome encodes more than 1500 transcription factors. These proteins have
a modular structure with distinct domains for DNA binding and transcriptional activation
(or repression). Stimulus-responsive transcription factors connect cellular stimulation with
gene transcription, involving protein kinases as signal transducers. These transcription
factors contain phosphorylation-responsive activation domains, that is, transcriptional
activation requires phosphorylation. In this article we discuss the molecular mechanism of
the transcriptional activation of the stimulus-responsive transcription factor Elk-1, which
is essentially involved in the control of cellular proliferation induced by mitogens, in
thymocyte development, glucose homeostasis and brain function. Elk-1 is a member of the
ETS family of transcription factors. The name ETS is derived from the avian erythroblastosis
virus E26, which encodes the v-ets oncogene. Its cellular counterpart, Ets-1, is the founding
protein of the ETS family of proteins. All family members bind to a similar DNA recognition
site, encompassing the sequence GGAA/T, using their DNA binding site, the Ets domain [1].
In this review, we focus on the essential role of numerous protein–protein interactions for
the activation of Elk-1, involving several protein kinases, a Ca2+/calmodulin-dependent
protein phosphatase, chromatin modifiers and the transcription factor SRF, which all work
in a sequential manner.
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2. The Serum-Response Element
Cells express receptors and ion channels to enable communication with their envi-
ronment. The stimulation of cells with hormones, neurotransmitters, cytokines, mitogens,
nutrients or metabolites can change their genetic program. This stimulus-regulated gene
transcription allows cells to respond to extracellular stimuli that are released by other cells
of the organism. Protein kinases function as signal transducers, leading to the activation
of stimulus-responsive transcription factors that bind to specific genetic elements. One
of these elements is the serum-response element (SRE) (Figure 1A), which facilitates gene
transcription as a result of cellular stimulation by extracellular signaling molecules. The SRE
is the binding site for the serum response factor (SRF) and the transcription factor Elk-1 or
related ternary complex factors (TCFs) (Figure 1A) [1,2]. An SRF dimer binds to the CArG
box with the consensus sequence CC[A/T]6GG, while the TCF proteins interact with the Ets
consensus core sequence GGAA/T, typical for the transcription factors of the ETS family. It
has been suggested that the binding of Elk-1 to DNA involves phosphorylation [3]. How-
ever, recent chromatin immunoprecipitation (ChIP) data showed that unphosphorylated
Elk-1 binds to DNA under basal conditions [4,5]. Likewise, the generation of the ternary
complex between Elk-1 and SRF occurs independent of Elk-1 phosphorylation [6].
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Figure 1. The serum-response element (SRE) provides binding sites for the serum response factor
(S F) a l - . ( ) e . ( ) l r str ct re of Elk-1 and related ternary complex factors,
showing the N-terminal DNA binding domain, the C-terminal activation domain and the B domain
that is required to interact with the SRF dimer.
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3. Modular Structure of Elk-1 and Other Ternary Complex Factors
The modular structures of Elk-1 and related ternary complex factors are depicted in
Figure 1B. The proteins share a similar domain structure, encompassing an N-terminal
DNA binding domain (A-box) and a C-terminal transcriptional activation domain (C-box).
The B domain which lies between the DNA binding and activation domains functions
as a “grappling hook” (M. Treisman) for the formation of the ternary Elk-1-SRF complex.
Thus, Elk-1 contacts a particular DNA sequence and binds to a dimer of the SRF in order
to generate a ternary complex. The three TCF proteins are ubiquitously expressed in
many cell types [7,8]. However, in embryonic stem cells Elk-1 expression is significantly
higher than the expression of SAP-1 and SAP-2 [9]. Elk-1 is a major nuclear substrate for
stimulus-responsive MAP kinases that phosphorylate serine residues S383 and S389 within
the transcriptional activation domain [10–16]. The phosphorylation of Elk-1 is induced by
the stimulation of the cells with ligands for G protein-coupled receptors, receptor tyrosine
kinases, cytokines or by the activation of ligand-gated and voltage-gated Ca2+ channels that
activate stimulus-responsive protein kinases in the cell. Elk-1 connects these intracellular
signaling cascades with SRE-dependent gene transcription (Figure 2). Phosphorylated Elk-1
is dephosphorylated by the Ca2+/calmodulin-dependent protein phosphatase calcineurin,
which functions as a negative feedback regulator of the stimulus-induced phosphorylation
and activation of Elk-1.
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cells with their environment. Ligands of G protein-coupled receptors, receptor tyrosine kinases and
cytokine receptors stimulate the cells as well as the activation of ligand- or voltage-gated ion channels
(TRP channels, voltage-gated Ca2+ channels). Upon stimulation of the cells with extracellular
signaling molecules, intracellular signaling cascades are initiated leading to the activation of the
MAP kinases extracellular signal-regulated protein kinase (ERK1/2), c-Jun N-terminal protein kinase
(JNK) and p38 protein kinase, which function as signal transducers. A rise in intracellular Ca2+
activates MAP kinases via stimulation of protein kinase C. MAP kinases translocate into the nucleus
and phosphorylate Elk-1 and related TCF, and thus activate SRE-controlled gene transcription. Elk-1
is dephosphorylated by the Ca2+/calmodulin-dependent protein phosphatase calcineurin.
4. Tools to Investigate Elk-1 Activity
The analysis of transgenic mice with a disruption of one of the TCF-encoding genes
revealed that the TCF proteins Elk-1, SAP-1 and SAP-2 share redundant functions resulting
from the structural homology between the TCF proteins [17–20]. Therefore, gene targeting
technology used to inactivate a single TCF-encoding gene was not useful for the inves-
tigation of TCF function. Additionally, double-transgenic Elk-1−/−/SAP-1−/− mice are
infertile [20]. It is therefore difficult to generate adult triple-transgenic Elk-1−/−/SAP-
1−/−/SAP-2−/− mice for assessing the role of TCF proteins in different tissues using
standard gene-targeting techniques and mice breeding.
The problem associated with the redundancy of functions between TCF proteins was
solved by the design and expression of a dominant-negative mutant of Elk-1, REST/Elk-
1∆C (Figure 3A). The mutant retains the domains for binding to DNA and to SRF, but
lacks the phosphorylation-regulated activation domain. REST/Elk-1∆C blocks the binding
sites of TCF proteins to DNA and interferes with the interaction of TCF proteins with SRF
because of the presence of the B domain in the Elk-1 mutant (Figure 3B). Additionally, the
expression of the truncated Elk-1 protein with a transcriptional repression domain, derived
from the transcriptional repressor REST, allows the recruitment of histone deacetylases to
the transcription units bound by REST/Elk-1∆C, inducing the chromatin compaction of
these sites.




Figure 3. A dominant-negative mutant of Elk-1 allows the investigation of the biological function 
of Elk-1. (A) Modular structure of Elk-1 and REST/Elk-1ΔC, showing the N-terminal DNA binding 
domain, the SRF binding site (domain B) and the C-terminal transcriptional activation domain. 
The REST/Elk-1ΔC mutant lacks the activation domain, but contains instead the N-terminal tran-
scriptional repressor domain from REST. (B) Mechanism of REST/Elk-1ΔC interference. The bind-
ing of TCF proteins to the SRE and to SRF is blocked. Additionally, histone deacetylases are re-
cruited to the transcription units. P, Elk-1 phosphorylation site. 
5. Biological Functions of Elk-1 
Elk-1 regulates the proliferation and apoptosis of several cell types, including astro-
cytes, fibroblasts, and pancreatic β-cells [8,21,22]. In primary astrocytes, the expression of 
the dominant-negative Elk-1 mutant REST/Elk-1ΔC completely blocks epidermal growth 
factor (EGF)-induced proliferation of the cells [21] (Figure 4A), indicating that Elk-1 activ-
ity is required for the mitogenic activity of EGF. The expression of REST/Elk-1ΔC in pan-
creatic β-cells of transgenic mice revealed that transgene expression resulted in the gener-
ation of significantly smaller islets (Figure 4B) [8]. Thus, an expression program involving 
Elk-1 or related TCF proteins is essential for the generation of islets of normal size. Ex-
pression of the dominant-negative mutant of Elk-1 strongly activates caspase-3/7 (Figure 
4C), enzymes that play critical roles in the execution phase of apoptosis. Thus, the activa-
Figure 3. Cont.
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5. Biological Functions of Elk-1
Elk-1 regulates the proliferation and apoptosis of several cell types, including astro-
cytes, fibroblasts, and pancreatic -cells [8,21,22]. In primary astrocytes, the expression of
the do inant-negative lk-1 t t Elk-1∆C completely blocks epider al gro th
factor (EGF)-induced proliferation of the cells [21] (Figure 4A), indicating hat Elk-1 ac-
iv ty is required for the mitogenic activity of EGF. The xpression of R ST/Elk-1∆C in
pancreatic β-cells of transgenic mice revealed that transgene expres ion resulted in the
generation of significant y smaller slets (Figure 4B) [8]. Thus, an expression pr gram
involving Elk-1 or related TCF proteins is essential fo the generation of islets of normal
size. Expression of the dominant-negative mutant of Elk-1 strongly activates caspase-3/7
(Figure 4C), enzymes that play critical roles in the execution hase of apoptosis. Thus,
the activation of apoptosis is responsible for the generation of smaller islets in transgenic
mice expressing the dominant-negative mutant of Elk-1 in pancreatic β-cells. As a result,
the transgenic mice showed impaired glucose tolerance [8] (Figure 4D). Elk-1 activity has
additionally been connected with the regulation of adipogenesis, thymocyte development
and brain function [17,20,23,24]. Several proteins of the ETS family of transcription factors
have been linked to tumor development and cancer [1]. The expression of v-ets, encoded
by the E26 virus, results in the development of erythroid and myeloid leukemias. The ETS
proteins PEA3 and ERG have been proposed to induce Ewing sarcomas and prostate cancer,
respectively. Elk-1 has been proposed to play a role in different cancer types. However, the
published studies do not allow for a general statement to be made regarding a correlation
between Elk-1 and tumor development.
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Figure 4. Biological functions of Elk-1. (A) Primary astrocytes were infected with a recombinant
lentivirus encoding REST/Elk-1∆C. As a control, mock-infected cells were analyzed. Cells were stim-
ulated with EGF (10 ng mL−1) for 24 h. DNA synthesis was measured by the incorporation of BrdU
into the DNA that was detected by an immunoassay (*** p < 0.001). (B) Attenuation of Elk-1 activity
in pancreatic β-cells resulted in the generation of significantly smaller islets. Transgenic mice were an-
alyzed that allowed the doxycycline (Dox)-dependent expression of the dominant-negative mutant of
Elk-1, REST/Elk-1∆C, specifically in pancreatic β-cells. H&E-stained sagittal sections of pancreata de-
rived from these mice that had received doxycycline supplementation in the drinking water showed
significantly smaller islets in comparison to control mice. (C) Inhibition of Elk-1 activated caspase-3/7.
INS-1 832/13 insulinoma cells were infected with a recombinant lentivirus encoding REST/Elk-1∆C
as indicated. The cells were incubated in DME medium containing 0.5% serum and 2 mM glucose
for 74 h. The caspase-3/7 activity was determined with the “CaspaseGlo-Substrate”. (D) Impaired
glucose tolerance in transgenic mice expressing REST/Elk-1∆C in pancreatic β-cells. A glucose
tolerance test was performed with 10 week-old double-transgenic RIP-rtTA/[tetO]7REST/Elk-1∆C
mice that were maintained either in the presence or absence of doxycycline (DOX) in the drinking
water. The animals were injected with glucose (2 g/kg body weight), and blood glucose levels were
measured at different time points. Blood glucose concentrations were determined (data shown are
mean +/− SEM or +/− SD; * p < 0.05; ** p < 0.01; *** p < 0.001; n = 3). Reproduced with modifications
from Refs. [8,21], with permission from the Company of Biologists, John Wiley and Sons and Elsevier.
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6. Essential Protein–Protein Interactions of Elk-1
6.1. Generation of a Ternary Complex with SRF: Role of DNA Binding and
Protein–Protein Interactions
Elk-1 and SRF are transcription factors that bind in a sequence-specific manner to
cognate DNA sites. Point mutations of the Elk-1 DNA binding site and the SRF DNA
binding site were used to determine the importance of DNA binding in general and of each
binding site in particular. The SRE derived from the c-Fos gene, and mutations leading to
an inactivation of Elk-1 DNA binding (∆Ets) or SRF DNA binding (∆CArG) are shown in
Figure 5A. Stimulation of the ERK1/2 signaling pathway via activation of a B-Raf mutant
induces c-Fos-promoter-regulated gene transcription. Mutational inactivation of either
the Elk-1 or the SRE DNA binding site leads to a significant reduction of SRE-mediated
transcription [25]. Thus, the DNA binding of both Elk-1 and SRF is required for B-Raf-
induced gene transcription via the SRE. SRE-mediated transcription is also activated by
stimulating transient receptor potential melastatin-3 (TRPM3) channels with the ligand
pregnenolone sulfate, mediated by an influx of Ca2+ into the cells (Figure 2). TRPM3
channels function as a noxious heat sensor in somatosensory neurons and have been
described to regulate insulin secretion [26,27]. TRPM3 stimulation activates the c-Fos
promoter. Mutation of the DNA binding site for SRF significantly impairs TRPM3-induced
activation of the c-Fos promoter, while mutation of the TCF DNA binding site (∆Ets)
has no effect on TRPM3-induced upregulation of gene transcription. Experiments with
the dominant-negative mutant of Elk-1 have shown that TRPM3-induced reporter gene
transcription is reduced in the presence of the Elk-1 mutant [28]. These data indicate that
Elk-1 is involved in TRPM3-induced gene transcription, although DNA binding is not
essential. We believe that Elk-1 is recruited to the SRE via protein–protein interaction
with SRF, which would not require DNA binding by Elk-1. Likewise, the activation of
SRE-regulated gene transcription following the stimulation of G protein-coupled receptors
was shown to require the DNA binding of SRF, but was independent of the DNA binding
site of Elk-1 [29–31]. Thus, SRE-regulated transcription requires the DNA binding of SRF,
which then recruits Elk-1 and other TCFs to the SRE. Elk-1 binds to DNA and SRF or only
to SRF via protein–protein interaction through its B-domain.
The B-domain of Elk-1 and other TCF proteins is necessary and sufficient for the
interaction with SRF. Deletion of the entire domain or mutation of a critical threonine
residue (T163) within the B-domain abolishes SRF binding [32]. This threonine residue is
also conserved between the three homologous TCF proteins (Figure 5B). Alanine scanning
mutations of the Elk-1 B-box identified four hydrophobic residues (Y153, Y159, F162 and
I164) involved in SRF binding [33]. These sites are also conserved in SAP-1 and SAP-2,
except for isoleucine residue 164 which is replaced by a leucine residue in SAP-1. An X-ray
structural analysis of the SAP-1 B-Box together with SRF showed that the hydrophobic
residues Y141, L246, F150 and L155 of SAP-1 contribute to the binding interface to SRF [34].
All four sites are conserved in Elk-1 and SAP-2, and the corresponding SAP-1 residues Y141
and F150 (Y153 and F162 in Elk-1) have also been identified via alanine scanning mutation
as necessary for SRF binding [33]. The X-ray structure of the SAP-1 B-box revealed that this
domain adopts a 310-helix/β-strand/310-helix conformation that allows the interaction to
SRF with a hydrophobic interface [34].
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6.2. Phosphoacceptor Motifs of Elk-1
ChIP experiments showed that unphosphorylated Elk-1 occupies the SRE of the c-Fos
and the Egr-1 promoters in the absence of stimulation. Following mitogenic stimulation,
DNA-bound phosphorylated Elk-1 is detectable 10 to 15 min after stimulation [4,5]. The
TCF proteins are substrates for three MAP kinases extracellular signal-regulated protein
ki ases (ERK1/2), c-Jun N-terminal protein kinase (JNK) and p38 protein kinase. These
kinases form a fa ily of structurally related protein kinases that are integrated into protein
kinase casc des th t include MAP kinase i s s (MAP2 kinases) and MAP kinase i s
i s (MAP3 kinases). MAP kinases are activated by numerous signaling molecules,
including ligands of G protein-coupled receptors, receptor tyrosine kinases, cytokine
receptors and various stress-induced agents such as osmotic or oxidative stress and UV
radiation [35–37].
MAP kinases are proline-directed serine/threonine kinases and several S-P or T-P
clusters are present within the transcriptional activation domains of Elk-1, SAP-1 and
SAP-2 which show high sequence conservation (Figure 6). Elk-1, SAP-1 and SAP-2 are
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all phosphorylated by ERK1/2 [7,38]. The serine residues S383 and S389 of Elk-1 have
been identified as major phosphoacceptor sites for ERK2 and JNK [10–16]. In particular,
the phosphorylation of S383 is important because mutation of this residue attenuates
the transactivation function of Elk-1 more than mutations of other serine or threonine
residues [11,12,14,16]. Kinetic experiments revealed that S383 and T368 of Elk-1 are phos-
phorylated very rapidly by ERK2, whereas residues T353, T363 and S389 show intermediate
phosphorylation kinetics. ERK2 additionally phosphorylates serine and threonine residues
outside of the C-Box (T336, T417, S423) [39]. JNK and p38 protein kinases phosphorylate
Elk-1, with differences for site preferences and kinetics being observed. In particular,
JNK shows a kinetic preference for T-P motifs, while p38 exhibits preferences similar to
ERK2 [39]. The residues S381 in SAP-1 and S357 in SAP-2 (corresponding to the phosphory-
lation site S383 in Elk-1) have been shown to be important for the transcriptional activation
of SAP-1 and SAP-2 [7]. Likewise, UV-radiation-activated JNK phosphorylates Elk-1 on
serine residues 383 and 389, and JNK-mediated transcriptional activation was abolished
when these residues were mutated to alanine [14]. ERK, JNK and p38 phosphorylate SAP-1
and SAP-2, although different results have been published about the phosphorylation of
SAP-1 by JNK [15,40–42]. The p38 protein kinase phosphorylates both Elk-1 and SAP-1
on residues within the C-terminal activation domain, and functions as signal transducer
connecting cytokine stimulation and TCF activation [15,43].
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Figure 6. Phosphorylation sites within the activation domain of TCF proteins. Amino acid sequence
of the transcriptional activation domains (C-box) of Elk-1, SAP-1 and SAP-2. The key phosphorylation
sites S383 and S389 are highlighted. Rapid (stars) and intermediate phosphorylation sites (bars) are
indicated. On the C-terminal end of the C-box is the second MAP kinase docking site (DEF site). In
addition, the Med23 binding site (F378, W379) is shown (M). The sequence information is derived
from Ref. [7].
6.3. Docking Sites for Stimulus-Responsive MAP Kinases
Protein kinases have been characterized by their recognition of a particular consensus
site which includes the phosphorylated residue. Often, short sequence motifs are recog-
nized (e.g., the S/T-P site for the proline-directed MAP kinases). These motifs are often
found several times in a protein, indicating that the recognition sequence alone cannot
provide protein kinase specificity. Moreover, MAP kinases recognize similar consensus
sites. Thus, the interaction of MAP kinases with other sites of the substrate proteins must
occur in order to increase substrate affinity and provide protein kinase specificity. Elk-1
has at least two protein kinase docking sites, the D-sites (or D-domain, D-Box) and the
DEF site. The D-domain encompasses a stretch of basic residues, a central proline residue
and a cluster of hydrophobic residues known as the docking groove [35] (Figure 7). These
sites are either conserved in the SAP-1 and SAP-2 molecules or replaced by similar charged
residues (exchange of a lysine residue for an arginine residue). The D-box also functions
as an ERK2 docking site in a heterologous context [44,45]. Activation of ERK2 is required
for efficient binding to the D-box of Elk-1 [44]. ERK2 and JNK bind to similar and distinct
amino acids of the D-box of Elk-1. Alanine scanning mutations underlined the importance
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of the basic amino acids R314 and K315 of Elk-1 N-terminal of the proline residue P316 and
the residues R317 and L319 C-terminal of this proline residue for the binding of ERK2 and
JNK. Mutation of the LEL cluster (amino acids 319–321) significantly reduced the docking
function of the D-box [46]. Mutation of residues L323 and S324 revealed an impairment
of JNK-induced Elk-1 phosphorylation. Additionally, exchange of the leucine residues
327 and 328 of Elk-1 with alanine residues completely blocked ERK2- and JNK-mediated
Elk-1 phosphorylation, suggesting that these residues are also involved in MAP kinase
docking. The leucine residues are not conserved in SAP-1 and SAP-2 but replaced by other
hydrophobic amino acids (Figure 7). Figure 7 depicts for comparison the JNK binding site
of the JNK-interacting protein JIP-1, showing that the N-terminal part of the D-box, includ-
ing the stretch of basic amino acids, the proline residue and the cluster of hydrophobic
amino acids, can be found in this protein as well [45]. In contrast to ERK2 and JNK, the p38
protein kinase does not use the D-box to bind to Elk-1 [45].
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Figure 7. Protein kinase docking sites within the TCF proteins. Amino acid sequence of the D-box
(D-domain, D-site) and the DEF site. The s qu nce informat on is d rived from Ref. [7]. Critical
amino acids of Elk-1 required for binding of P i it t rs. seq ence of the
JNK docking site to the JNK-interacting protein-1 (JIP-1) is also depicted. The box shows a proline
residue present in TCF proteins and JIP-1.
The second MAP kinase docking site is the DEF site, named after “docking site for
ERK, FXF” [46]. Within the Elk-1 protein, the sequence FQFP is found C-terminal to the
transcriptional activation domain. The motif FXFP is an evolutionarily conserved ERK
docking site and functions independently of the D-box in Elk-1 protein. Likewise, ERK
interacts with the D-box even when the DEF site is mutated [46]. SAP-1 and SAP-2 contain
a DEF site as well (Figure 7). The DEF site functions as docking site for ERK1/2 and p38
protein kinases, while JNK does not interact with this site [39,45–47].
The fact that ERK interacts with Elk-1 involving two docking sites, the D-box and the
DEF site indicates that ERK binds with higher affinity to Elk-1 than JNK or p38, which
use either the D-box (JNK) or the DEF site (p38) for interaction. These different docking
modules function independently and additively and result in different binding affinities
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for MAP kinases with a particular substrate [46]. Moreover, the docking site influences the
phosphorylation site in proteins with multiple potential phosphorylation consensus sites.
The binding of ERK to the DEF site directs phosphorylation of S383 in Elk-1, while binding
of the kinase to the D-box results in the phosphorylation of other serine and threonine
residues of Elk-1 [48].
6.4. Phospho-Elk-1 Interacts with the Mediator Complex
Experiments with cells derived from knockout mice revealed that expression of the
mediator of RNA polymerase II transcription (Mediator) subunit 23 (Med23) is essential for
stimulus-induced biosynthesis of the transcription factor Egr-1 [49,50]. The Mediator multi-
protein complex consists of 20–30 subunits that function as a bridge between DNA-bound
transcription factors, RNA polymerase II and general transcription factors. It transduces
the signal from DNA-bound transcriptional activators to the transcriptional machinery [51].
As Egr-1 expression is controlled by Elk-1 or related transcription factors, the control of
Elk-1 transcriptional activity by Med23 was investigated in the Berk lab. The transcriptional
activation potential of Elk-1 was almost completely blocked in stimulated ES cells lacking
Med23, while the expression of Med23 restored Elk-1 activity. Med23 bound specifically to
phosphorylated Elk-1 [49], thus connecting Elk-1 phosphorylation with gene transcription.
These data were corroborated in chromatin immunoprecipitation experiments showing
that serum-induced phosphorylation of Elk-1 upregulates Mediator binding to the Egr-1
promoter region in ES cells, while this interaction is almost abolished in ES cells lacking
Med23 [50]. A hydrophobic region within the transcriptional activation domain of Elk-1,
including the residues F378 and W379, functions as docking site for Med23. Mutation of
these residues to alanine residues completely abolishes the stimulus-induced transcrip-
tional activation of Elk-1 [7]. However, the interaction of Med23 with the hydrophobic
region of Elk-1 is not sufficient for binding, as shown in coprecipitation experiments of
Elk-1 and Med23 [49]. Med23 additionally interacts with phosphorylated residues within
the activation domain of Elk-1, leading to a stabilization of the protein–protein interaction
and to an increased recruitment of RNA polymerase II to the transcription unit [9]. A recent
analysis of multi-site phosphorylation of Elk-1 revealed that Elk-1–Mediator interaction
was promoted by the phosphorylation of the fast and intermediate phosphoacceptor sites,
while phosphorylation of the slow phosphorylation sites located outside of the activation
domain counteracted Elk-1 activity by inhibiting Mediator recruitment [39]. Thus, the
sequential phosphorylation of Elk-1 induces an activation of Elk-1, and later induces an
inhibition of Elk-1, controlled by the interaction of phospho-Elk-1 with the Mediator com-
plex. In addition, fully phosphorylated Elk-1 may additionally recruit the transcriptional
repressor mSin3A to block gene transcription. The analysis of TCF–Mediator interaction
further revealed that the TCF proteins interact differently with Med23. While Med23 is
essential for Elk-1-regulated gene transcription, the transcriptional activation potential of
SAP-2 is only marginally affected by the loss of Med23 [9], suggesting that other Mediator
subunits connect SAP-2 with RNA polymerase II and the general transcriptional apparatus.
6.5. Protein–Protein Interaction of Elk-1 with the Histone Acetyltransferase p300
The transcriptional coactivators p300 and CREB binding protein (CBP) are involved in
the regulation of many transcription factors, including CREB, nuclear hormone receptors,
p53, c-Jun, c-Fos and many others [52]. CBP and p300 are histone acetyltransferases
that catalyze the transfer of acetyl groups derived from acetyl-CoA to lysine residues
of histones or other proteins. The acetylation of histones H3 and H4 is correlated with
an open chromatin structure, facilitating the binding of transcription factors and RNA
polymerase II to DNA. Elk-1 interacts with p300, even in the absence of stimulation (and
phosphorylation). However, the phosphorylation of Elk-1 on serine residues S383 and
S389 increases the affinity of Elk-1 to p300, which involves an additional interaction site
within the p300 molecule. Moreover, the intrinsic histone acetyltransferase activity of
p300 is dramatically increased. Mutation of the serine residues S383 and S389 to alanine
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prevents this increase in histone acetyltransferase activity [53]. Thus, the phosphorylation
of Elk-1 induces the transcriptional activation by the recruitment of the Mediator complex
and by interaction with the p300 coactivator, which leads to changes in the chromatin
structure. In mouse embryonic fibroblasts it has been shown that the generation of these
chromatin modifications requires phosphorylated and transcriptionally active Elk-1 [6].
p300 functions as bridge between Elk-1 and the general transcriptional machinery.
6.6. Calcineurin Catalyzes Dephosphorylation and Inactivation of Elk-1
The stimulus-induced upregulation of a biological activity requires a shut-off mech-
anism. Naturally, since Elk-1 is activated by phosphorylation, dephosphorylation is
connected with the inactivation of Elk-1-mediated gene transcription. Kinetic studies
have shown that the EGF-induced phosphorylation of Elk-1 on serine residue S383 is
already strongly visible 15 min after stimulation, whereas after 60 min much lower levels
of phospho-Elk-1 are detected [5,53]. The dephosphorylation and inactivation of phos-
phorylated Elk-1 is catalyzed by the Ca2+/calmodulin-dependent protein phosphatase
calcineurin [54,55]. Specifically, calcineurin catalyzes the dephosphorylation of S383 of
Elk-1 [55]. Calcineurin consists of the catalytic subunit A and the regulatory subunit B.
Calcineurin A has a long catalytic domain and binding sites for calcineurin B and calmod-
ulin (Figure 8A). An autoinhibitory domain is located on the C-terminus, which binds to
the catalytic center in the absence of Ca2+ ions. A rise in intracellular Ca2+ activates cal-
cineurin [56]. Experimentally, calcineurin can be activated by the expression of a truncated
calcineurin A mutant (∆CnA) (Figure 8A). The expression of ∆CnA significantly reduces
the transcriptional activation potential of Elk-1 in cells expressing an activated G protein-
coupled designer receptor (Rαq). Likewise, ∆CnA expression reduces the biosynthesis of
the Elk-1-regulated target gene c-Fos (Figure 8B) [57]. ∆CnA expression also reduces the
promoter activities of Egr-1 and c-Fos [57,58]. In the calcineurin-regulated transcription fac-
tor NFAT, a short binding site for calcineurin has been found, encompassing the sequence
PxIxIT [59]; however, no such site is present in the Elk-1 molecule. Thus, the mechanism
by which calcineurin binds to phospho-Elk-1 is currently unknown.
6.7. Recruitment of the mSin3A–Histone Deacetylase Complex to Highly Phosphorylated Elk-1
A quantitative analysis of multisite phosphorylation of Elk-1 revealed that phospho-
rylation of the “slow” sites T336, T417 and S422 of Elk-1 counteracted transcriptional
activation and interaction with the Mediator complex [39]. These data indicate that the
duration of Elk-1 activation is limited by progressive ERK2-catalyzed phosphorylation. The
molecular mechanism of this inhibition lies in the recruitment of the corepressor mSin3A, a
multiprotein complex which binds to the N-terminal repression domain of Elk-1 (amino
acids 1–93), which overlaps with the DNA binding domain (Figure 9). This recruitment of
mSin3A is stimulated by the phosphorylation of Elk-1 and correlates with the downregu-
lation of c-Fos expression, encoded by a prominent target gene of Elk-1 [60]. Thus, there
is a temporal delay between the fast phosphorylation of Elk-1 and the recruitment of the
mSin3A complex. mSin3A has been described to be associated with histone deacetylase
activity. Accordingly, pharmacological experiments using trichostatin A (TSA), an inhibitor
of histone deacetylases, suggest that mSin3A recruits histone deacetylases to Elk-1. These
enzymes catalyze the removal of the acetyl groups from histones, allowing ionic inter-
actions between positively charged amino acids of histones and the negatively charged
phosphate groups of the DNA. This results in a compaction of the chromatin structure,
which is accompanied by a repression of gene transcription. Interestingly, binding of the
histone deacetylase HDAC-1 to Elk-1 was shown to be enhanced following activation of
the ERK signaling pathway [54].
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Molecules 2021, 26, 6125 14 of 17
6.8. A SUMO–Histone Deacetylase Complex Binds to Elk-1 in the Absence of Stimulation
Elk-1 contains a second portable repressor domain, the R motif (Figure 9), that func-
tions in reducing the transcriptional activity of Elk-1 under basal conditions [61]. The
Elk-1-related proteins SAP-1 and SAP-2 lack this R motif, but have other distinct repression
domains. Within the R motif of Elk-1 there are two lysine residues K230 and K249 that
function as acceptor sites for the ubiquitin-like protein SUMO, which is conjugated to
the lysine residues of proteins involving an activating enzyme (E1), a conjugating en-
zyme (E2) and a ligase (E3). This modification is responsible for the repression activity
of the R motif and is overcome by mutating the lysine residues K230 and K249 to argi-
nine residues [62]. The lysine residues are part of the SUMO consensus site ψKxE (ψ,
hydrophobic amino acid; x, any amino acid). In addition, acidic residues C-terminal to
the SUMO consensus site are involved in SUMO binding, probably by enhancing binding
of the SUMO-conjugating enzyme UBC9 [63]. The repression activity mediated by the R
motif is TSA sensitive, indicating that SUMO functions via processes catalyzed by histone
deacetylases. In fact, recruitment of the histone deacetylase HDAC-2 to Elk-1 occupied
promoters has been shown [62,63]. These data indicate that the transcriptional repression
of Elk-1 is mediated by the SUMO-dependent recruitment of histone deacetylases, which
induces a chromatin compaction of Elk-1-bound genes. The phosphorylation of Elk-1
results in a loss of SUMO and HDAC-2 binding and therefore induces a de-inhibition
of Elk-1 activity [62–64]. After phosphorylation and activation, Elk-1 is dephosphory-
lated, which allows its re-SUMOylation. Together, the R motif functions in keeping Elk-1
transcriptionally inactive under basal conditions.
7. Conclusions
Elk-1 is a DNA binding protein that interacts with a genetic element termed the “serum
response element”. Biochemical and genetic investigation showed that the biological activ-
ity of Elk-1 is controlled by numerous protein–protein interactions. In fact, protein–protein
interaction with the serum response factor may replace Elk-1–DNA interaction in some
signaling pathways. Elk-1 is kept in an inactive state under basal conditions via the binding
of a SUMO–histone deacetylase complex. A model has been formulated according to
which Elk-1 exists under basal conditions as a “transcriptionally poised complex” [59] that
is rapidly activated by cellular stimulation. The activation of MAP kinases, particularly
ERK1/2, triggers a de-SUMOylation of Elk-1, leading to the phosphorylation and activation
of Elk-1. The transcriptional activation potential of phosphorylated Elk-1 is enhanced by
the interaction with subunits of the Mediator complex and binding of the histone acetyl-
transferase p300, leading to changes of the chromatin architecture. Strong and extended
phosphorylation of Elk-1 attenuates Mediator recruitment and transcriptional activation
by attracting the mSin3A–histone deacetylase complex. Moreover, phosphorylated Elk-1 is
dephosphorylated by the Ca2+/calmodulin-dependent protein phosphatase calcineurin.
Dephosphorylated Elk-1 is then re-SUMOylated to put Elk-1 back into an inactive state,
waiting for the next cycle of stimulation and activation (Figure 10).
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calcineurin. Dephosphorylated Elk-1 is then re-SUMOylated to put Elk-1 back into an in-
active state, waiting for the next cycle of stimulation and activation (Figure 10). 
 
Figure 10. The Elk-1 activation cycle. 
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